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Abstract
In the last decades, several European countries where arboviral infections are not endemic
have faced outbreaks of diseases such as chikungunya and dengue, initially introduced by
infectious travellers from tropical endemic areas and then spread locally via mosquito bites. To
keep in check the epidemiological risk, interventions targeted to control vector abundance can
be implemented by local authorities. We assessed the epidemiological effectiveness and eco-
nomic costs and benefits of routine larviciding in European towns with temperate climate, using
a mathematical model of Aedes albopictus populations and viral transmission, calibrated on
entomological surveillance data collected from ten municipalities in Northern Italy during 2014
and 2015.We found that routine larviciding of public catch basins can limit both the risk of
autochthonous transmission and the size of potential epidemics. Ideal larvicide interventions
should be timed in such a way to cover the month of July. Optimally timed larviciding can
reduce locally transmitted cases of chikungunya by 20% - 33% for a single application (dengue:
18–22%) and up to 43% - 65% if treatment is repeated four times throughout the season (den-
gue: 31–51%). In larger municipalities (>35,000 inhabitants), the cost of comprehensive larvi-
ciding over the whole urban area overcomes potential health benefits related to preventing
cases of disease, suggesting the adoption of more localized interventions. Small/medium sized
towns with high mosquito abundance will likely have a positive cost-benefit balance. Involve-
ment of private citizens in routine larviciding activities further reduces transmission risks but
with disproportionate costs of intervention. International travels and the incidence of mosquito-
borne diseases are increasing worldwide, exposing a growing number of European citizens to
higher risks of potential outbreaks. Results from this study may support the planning and timing
of interventions aimed to reduce the probability of autochthonous transmission as well as the
nuisance for local populations living in temperate areas of Europe.
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Author summary
Larvicides are a key tool to prevent the growth of mosquito populations and decrease both
the risks of outbreaks of mosquito-borne diseases and the nuisance deriving from bites. In
order to assist municipalities from temperate areas in Europe in effectively planning vec-
tor control programs, we modelled the effect of larviciding in public areas on populations
of Aedes albopictus using mosquito collection data from 10 municipalities in Northern
Italy, over two years with very different temperature conditions. We then evaluated the
resulting probabilities of potential outbreaks of chikungunya and dengue and their
expected final sizes, and we compared the intervention costs to the economic and health
benefits due to the avoidance of clinical cases. By assessing several different intervention
strategies, we found that the optimal timing should be centred on the month of July, cor-
responding to the period of maximal growth of the mosquito population. Municipality-
wide interventions are likely to be cost-effective in small-to-medium towns (below 35,000
inhabitants) even where mosquito infestation is moderate, whereas for larger cities a
neighbourhood-based intervention should be considered. The involvement of citizens to
apply larvicides within private premises resulted effective but generally too costly.
Introduction
During the last decade, Europe has faced outbreaks of mosquito-borne diseases (MBD) such as
dengue and chikungunya, following the continuous importation of human cases in areas with
established competent vectors such as the invasive mosquito Aedes (Stegomyia) albopictus
(Skuse) [1]. Vector control interventions can be implemented by local authorities to keep in
check mosquito abundance and consequently reduce the epidemiological risk. Adulticide
spraying rapidly reduces the number of mosquitoes, but its effect is short-lived [2]. For this
reason, it is particularly indicated in situations where the transmission risk needs to be reduced
drastically and quickly, such as when an individual is diagnosed with an MBD, to prevent or
curtail an outbreak [3]. Since the effectiveness of reactive measures decreases with the delay
between outbreak initiation and implementation of control [4], a better approach may consist
in preventive interventions. Treatment of potential breeding sites with larvicide products has a
delayed impact in reducing adult populations [3], but experimental studies show that their
effect lasts for several weeks [5], making them better suited for preventive routine control. The
main limit to larviciding as a control option is the proportion of breeding sites that are actually
accessible to interventions by public health authorities. To overcome this limit, education cam-
paigns may be carried forward to encourage citizens to remove and treat potential breeding
sites from their private premises during the mosquito season [6, 7]. Mathematical modelling of
MBD associated with cost-effectiveness analyses can help optimizing routine vector control
interventions [8] with respect to constraints in human and financial resources [9].
With the aim of assisting European municipalities in planning and timing preventive vector
control, we assessed the potential epidemiological impact on chikungunya and dengue, and
the ensuing economic benefits for the health system, produced by routine larviciding against
Ae. albopictus within urban sites in temperate climates.
Methods
Mosquito data
Mosquito monitoring via adult trapping was carried out in ten municipalities from the North-
ern Italian provinces of Belluno and Trento, characterized by a temperate climate [10].
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Mosquitoes were collected using Biogents (BG) Sentinel traps (Biogents AG, Regensburg, Ger-
many) baited with lures and CO2 from dry ice. After each trapping session, mosquitoes were
killed by freezing at -20˚C, identified using taxonomic keys [11, 12] and confirmed by PCR if
found in a location for the first time [12].
Transmission dynamics model
We simulated the transmission dynamics associated with chikungunya and dengue using a
standard SEI-SEIR approach [13] in which mosquitoes develop lifelong infection after an
(extrinsic) incubation period since the bite to an infectious human (SEI sub-model), whereas
humans develop temporary infection, followed by the development of immunity, after an
(intrinsic) incubation period since the bite from an infectious mosquito (SEIR sub-model).
We considered temperature-dependent extrinsic incubation periods and per-bite transmission
probabilities for dengue [14], whereas only temperature-independent estimates were available
for Chikungunya [15, 16]. The transmission model was initialized with a single infectious
human, representing an imported case at a date sampled uniformly between January 1st and
December 31st. The population size of female Ae. albopictus mosquitoes over time in the trans-
mission model was estimated by fitting a population model to capture data collected in the
absence of larvicidal treatments, following the same approach already adopted in [13, 17]. The
model considers four developmental stages of mosquitoes (eggs, larvae, pupae and adults) and
reproduces their life cycle by means of temperature-dependent parameters regulating the
stage-specific rates of mortality and development. Free model parameters (i.e. the site- and
year- specific habitat suitability and the capture rate of BG traps) were estimated via a Monte
Carlo Markov Chain approach based on a Poisson likelihood [13, 17].
We then included the effect of routine larviciding in the population model. Experimental
studies of several available commercial larvicide products show that 99% of existing larvae and
hatching eggs are killed within a given breeding site, with constant efficacy of about 30 days,
independently of the specific product used [5, 18, 19]. We considered a standard approach tar-
geting breeding sites in publicly accessible spaces (e.g., catch basins placed in public parks and
along the road system), and an additional strategy where public interventions were integrated
by the involvement of citizens in treating and removing breeding sites within private premises.
The latter was parametrized on results from a pilot project conducted in two municipalities
within the same area of this study [7], in which larvicide products were delivered door-to-door
and free of charge to house dwellers, who were sensitized and educated to mosquito control
interventions. A key determinant of effectiveness is the fraction of existing breeding sites in a
given area that are actually treated (coverage). We adopted a coverage range between 30% and
50% for larviciding of public catch basins only, and between 60% and 75% for interventions
that additionally involve citizens. These ranges were computed from available data on the den-
sity and proportion of reachable breeding sites in public and private premises [7]. Other strate-
gies aimed at extending the coverage (e.g. removal of other breeding sites such as water
buckets, plant saucers, tarpaulins, etc.) were not considered.
Since the effect of larvicides is transitory, treatment of catch basins may be repeated multi-
ple times within a given season. We considered several different starting dates and from 1 to 4
applications of larvicide treatments within a given mosquito season (hereafter referred to as
“effort level”), implemented with monthly frequency.
Economic assessment
To evaluate the economic acceptability of the two considered strategies, a cost-utility analysis
for the prevention of dengue and chikungunya was conducted, taking the number of infections
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as input from the transmission model. Disability Adjusted Life Years (DALYs) averted and net
costs were derived comparing an intervention scenario to the case in which no control pro-
grams were put in place (baseline). The baseline was set to reflect a municipality where only
the monitoring of mosquito presence via ovitraps was performed [7].
The analysis was conducted from a public healthcare system perspective through the maxi-
mization of the net health benefit (NHB) [20]. This measure is defined as the difference
between the DALY averted and the incremental cost due to the intervention, the latter divided
by the willingness to pay (WTP) by public authorities for each DALY averted. Following
WHO recommendations [21], we assumed such value approximately equal to the Gross
Domestic Product (GDP), which is about 35,000 euro per capita in our study area [22].
Probabilities of each infected case of being symptomatic, notified, severe, hospitalized and
of dying, and the length of stay in hospital, were derived from published studies [23, 24] and
from analyzing data from the Italian Hospital Discharge System (Schede di Dimissioni Ospe-
daliere), accounting for all hospital admissions for chikungunya and dengue recorded in Italy.
The cost of illness was estimated according to expert opinion. The costs of intervention were
estimated from actual costs during control activities against Ae. albopictus recently performed
in two municipalities from the study area [7].
For all the considered scenarios, the NHB was computed on a set of 100,000 stochastic reali-
zations accounting for the uncertainty in both the transmission and the economic model’s
parameters. Full details on this analysis are provided in S1 Text.
To assess the feasibility and sustainability of public interventions, we used responses from a
questionnaire administered in 2013 to municipalities of the province of Trento, aimed at col-
lecting information on the actual public expenditure on vector control activities.
Results
The estimated density of adult female mosquitoes (averaged between April 10th and September
30th) was between 4 and 88 per hectare in 2014 and between 9 and 198 in 2015, depending on
the municipality (see Table 1). The higher abundance in 2015 is mostly due to the much higher
Table 1. Estimated mosquito densities (average between April 10th–September 30th) and other relevant characteristics of the considered
municipalities.
Municipality Mosquito density
(adult mosquitoes /
ha)
Population (inhabitants) Urban surface (ha) Population density (inhabitants / ha)
2014 2015
Strigno * 3.8 8.9 3354 85 39.5
Belluno 9.8 27.1 35703 539 66.2
Tenno 14.1 88.9 1823 23 79.3
Tezze** 19.9 72.1 1742 36 48.4
Povo 42.4 138.5 5571 88 63.3
Santa Giustina 46.4 95.6 6800 159 42.8
Trento 52.3 128.4 117304 1570 74.7
Riva del Garda *** 72.7 197.5 32259 418 77.2
Feltre 74.2 161.1 20560 329 62.5
Rovereto 87.6 - 39099 444 88.1
*: includes the neighbouring municipality of Telve
**: includes the neighbouring municipality of Villa Agnedo
***: includes the neighbouring municipality of Arco
https://doi.org/10.1371/journal.pntd.0005918.t001
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temperatures recorded during summer. The initial reproduction numbers and the threshold
for autochthonous transmission of chikungunya and dengue over time were estimated in a
previous study [17]. Here, for each site and year, we computed the probability of autochtho-
nous transmission of chikungunya and dengue originated by an imported infection in the
absence of interventions. Higher vector densities during 2015 resulted in an increased risk of
local transmission for both infections, compared to the previous year. The probability of
observing at least one secondary case was estimated to be up to 30% for chikungunya and 15%
for dengue in highly infested towns in 2015. Corresponding maximum probabilities in 2014
were around 20% for chikungunya and 5% for dengue. This means that 7 importations of chi-
kungunya and 15 importations of dengue in towns most at risk would have a>90% probability
of causing at least one secondary case in 2015. Sporadic transmission (less than 10 secondary
cases) is by far the most likely scenario, especially for dengue (Fig 1). However, we found a
low, but non-negligible, probability (up to 2.7%) that an uncontrolled chikungunya outbreak
would produce more than 50 cases in several sites during 2015.
Routine preventive larvicide treatments can reduce significantly mosquito populations and
consequently the probability and size of outbreaks triggered by sporadic importation of
infected cases. To evaluate the overall effectiveness, we considered the expected number of
total secondary infections per imported case. Under the baseline scenario of no control inter-
ventions, this index ranged from 0.1 to 5.2, depending on the site and year; corresponding
numbers for dengue were everywhere below 0.5. Because of the smaller epidemiological risk of
dengue, we discuss only the cost-effectiveness analysis on chikungunya, leaving corresponding
results for dengue to the S1 Text.
For each site and year, and for each timing, effort level and assumed coverage, we evaluated
the relative reduction in the expected number of secondary infections per imported case as a
measure of effectiveness. Fig 2 and Table 2 show that all interventions with optimal effective-
ness covered the month of July, which corresponds to the estimated period of steepest growth
of the adult Ae. albopictus population in both years. We selected for further analyses only inter-
ventions with optimal timing for each effort level (Table 2; the reduction in mosquito abun-
dance corresponding to the optimally timed interventions is reported in the S1 Text). We
found that an increase in the effort level does not proportionally reduce the expected number
of cases (Fig 3). In particular, an expansion in the coverage of breeding sites from 30% to 50%
would be more effective than doubling the effort level while keeping the coverage at 30%. In
general, interventions are most beneficial when the baseline risk is highest.
Towards an optimal allocation of resources, the benefits of reducing the potential number
of transmitted cases needs to be compared with the intervention costs. Taking into account all
possible clinical outcomes, including the probability of severe illness and of hospitalization,
the estimated average cost per infection is 424.9 euros (95% CI 342–533) for chikungunya and
275.88 euros (95% CI 151–422) for each dengue infection. The corresponding average DALY
loss per case is higher for chikungunya (0.45, 95% CI 0.10–1.12) than for dengue (0.29, 95% CI
0.15–0.44). In Fig 4, we show the relative probability that each effort level (including the no-
intervention scenario) will maximize the NHB for each site, year, and coverage. Three main
outcomes can be identified. The first is represented by larger cities (Trento, Belluno and
Rovereto, all above 35,000 inhabitants) where non-intervention has the highest likelihood of
being optimal. In these sites, the poor economic effectiveness of larviciding depends on the rel-
atively low number of expected secondary cases even in the absence of treatment (Fig 3), com-
bined with the high intervention costs due to the extent of the area to be covered. The second
group consists of smaller towns where intervention is always beneficial (Povo, Santa Giustina,
Tenno and Tezze, all below 10,000 inhabitants) and where higher effort levels have the highest
probabilities of being optimal. Strigno (about 3,400 inhabitants) represents an exception to
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Fig 1. Epidemiological predictions in the absence of control interventions. Probability of local
transmission of chikungunya (CHIKV) and dengue (DENV), disaggregated by outbreak size, in the 10 study
locations during the mosquito seasons.
https://doi.org/10.1371/journal.pntd.0005918.g001
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this rule, where the low intervention costs are counterbalanced by a very small transmission
risk in the absence of interventions. Nonetheless, even in Strigno a low-effort intervention
(single treatment) might be beneficial because of its low cost. The third situation occurs in
towns of intermediate size (Feltre and Riva del Garda, between 20,000 and 35,000 inhabitants)
where both the intervention costs and the transmission risks are high. In these cases, depend-
ing on the larviciding coverage, absence of intervention might be the optimal strategy in sea-
sons of lower mosquito abundance (2014) while a low-to-moderate effort (1 to 3 treatments)
might be the best choice in years of high infestation (2015). Overall, the probability that a
more intensive intervention will be optimal increases with the coverage and with higher trans-
mission risk (2015 vs. 2014). We also tested the cost-effectiveness of expanding the coverage
Fig 2. Effectiveness of larviciding in reducing the expected number of secondary CHIKV infections.
Distribution across all sites and both years, disaggregated by coverage value (lighter colour: 30%; darker
colour: 50%), intervention timing (starting date every 15 days between May 1st and September 1st) and effort
level (i.e., number of larvicide applications with monthly frequency (from 1 to 4). Grey bars: optimal starting
date; shaded area: duration of intervention.
https://doi.org/10.1371/journal.pntd.0005918.g002
Table 2. Timing of optimal intervention and estimated reduction in the number of chikungunya cases at 30% and 50% coverage (mean and range
across all sites) by effort level (one to four larvicide applications over a season).
Effort level Optimal starting date End of efficacy, optimal timing Reduction in number of CHIKV cases, % (range)
30% coverage 50% coverage
1 intervention July 1st August 1st 18.6 (0–36.4) % 33.3 (13.9–48.9) %
2 interventions June 1st August 1st 32.3 (6.9–49.8) % 51.2 (27.7–66.6) %
3 interventions May 15th August 15th 40.5 (20.8–54.4) % 61.5 (39.0–74.0) %
4 interventions May 1st September 1st 43.1 (23.7–57.3) % 64.9 (39.2–77.2) %
https://doi.org/10.1371/journal.pntd.0005918.t002
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Fig 3. Estimated effectiveness of optimally timed interventions for different coverages (30% and 50%)
and effort level (0–4), disaggregated by site and year.
https://doi.org/10.1371/journal.pntd.0005918.g003
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Fig 4. Probability of highest net health benefit according to the number of larvicide treatments,
disaggregated by year, coverage and study site.
https://doi.org/10.1371/journal.pntd.0005918.g004
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by involving private citizens [7]. We found that this type of intervention might achieve signifi-
cant additional reductions in the expected number of secondary cases and probability of local
transmission (reported in the S1 Text). However, they are rarely optimal from the economic
perspective because they require labour-intensive activities. Fig 5 reports results of the NHB
analysis for a single larvicide treatment, but qualitative inferences are similar for more inten-
sive efforts (see S1 Text). The only two instances where involvement of citizens was found to
be economically beneficial were Povo and Tezze and only during the 2015 mosquito season,
i.e. only where the urban size is small enough to keep intervention costs low and where the
transmission risk at baseline is sufficiently high.
Two municipalities under study, Trento and Riva del Garda, had responded to a previously
administered questionnaire on public expenditure on vector control, declaring an overall
budget of 0.254 euro and 0.532 euros per inhabitant, respectively. In Trento, the most cost-
effective activity predicted by our model was monitoring by ovitraps (Fig 4), which has an esti-
mated average cost of 0.016 euro per inhabitant; in Riva del Garda, one or two larvicide appli-
cations per year would be likely optimal and would cost between 0.256 and 0.512 euros per
inhabitant. Therefore, the most cost-effective strategies are sustainable with respect to the cur-
rent allocated budget. We provide full details on questionnaires, municipality-specific answers
and intervention costs in the S1 Text.
Discussion
In this work, we evaluated the effect of routine larviciding against dengue and chikungunya,
two viruses transmitted by bites of Ae. albopictus mosquitoes. We used data from two seasons
of entomological surveillance in multiple sites from northern Italy to parametrize a mathemat-
ical model of mosquito population dynamics and control. The population model was coupled
with a transmission dynamics model and a cost-effectiveness analysis to identify suitable rou-
tine vector control strategies for temperate climate municipalities in Europe. We found that, in
the absence of interventions, the risk of autochthonous dengue transmission was low and lim-
ited to sporadic transmission in both years, because of the relatively low competence of Euro-
pean strains of Ae. albopictus. On the other hand, the risk of a chikungunya outbreak was
estimated to be up to 30% in 2015, with a non-negligible probability of observing outbreaks
larger than 50 cases in most sites.
We found that the most effective interventions in reducing the amount of expected locally
transmitted cases were those for which the window of larvicide efficacy covered at least the
month of July (Fig 2, Table 2). Larviciding reduced the probability of secondary cases only
moderately, but it had an important impact in avoiding larger outbreaks. Our analysis
included two seasons that were representative of a broad range of mosquito abundances, due
to the remarkable temperature differences. The cost-effectiveness of larviciding depends on
the actual mosquito abundance in a given year; however, general rules could be identified
independently of the considered year: small villages (<10,000 inhabitants) with moderate-to-
high mosquito abundances will maximally benefit of intense larviciding efforts made of sea-
son-round monthly treatment of public catch basins. For medium-sized towns (20–35,000
inhabitants) with high infestation rate, the benefits are partially offset by the higher cost of
intervention; in these cases, a moderate larviciding effort (1 to 3 treatments within the season)
is recommended. Larger cities in our study (>35,000 inhabitants) were characterized by a low
or intermediate transmission risk, and the high costs of an intervention covering the entire
urban area made it economically disadvantageous. In these situations, treating specific neigh-
bourhoods with highest mosquito abundance (called ‘hot spot’ approach [25]) may be cost-
effective. In order to evaluate such a scenario, however, it would be necessary to model the
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Fig 5. Probability of highest net health benefit for a single larvicide application according to the type
of intervention (none vs. public vs. public and private), by year, coverage (30 and 50% for public
intervention; 60 and 75% for both public and private intervention) and study site.
https://doi.org/10.1371/journal.pntd.0005918.g005
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complex effect of the urban layout on the spatial distribution of breeding sites and on the
dynamics of mosquito populations [7], which is out of the scope of our study. Treatment of
private breeding sites via the direct involvement of citizens by door-to-door visits was recom-
mended only in small towns with high mosquito infestation. A survey on the allocated budget
for mosquito control programs across different municipalities showed that expenses required
for the most cost-effective interventions are sustainable for the considered area.
These results need to be contextualized with respect to our simplifying assumptions. First,
all results are given conditionally on a uniform probability of importation of an infectious indi-
vidual within a given epidemiological year. For comparison, in the considered provinces of
Trento and Belluno, three imported cases of dengue and one imported case of chikungunya
were recorded in 2014 (C. Rizzo, personal communication); however, the actual importation
rate may vary significantly by year and time of the year, depending on spatio-temporal patterns
of global epidemics and international travel. We did not consider reactive interventions that
are implemented when a case of chikungunya or dengue infection is detected or after an out-
break has started (e.g., insecticide air spraying in the neighbourhood of the index case [26]). In
addition, our results are relative to the prevention of arboviral transmission; however, there
may be other purposes in vector control activities, such as the reduction of nuisance for citi-
zens, which were not included in our analysis. For what concerns the economic assessment,
we did not consider the impact of local transmission detection on the blood supply chain.
Upon clinical confirmation of a locally transmitted arboviral infection, restrictions on the
usage of blood bags collected in the region are applied to prevent transmission via transfusions,
and screening tests on available blood supplies are implemented [26]. These additional inter-
ventions are quite expensive, and savings associated to the reduction of transmission risk
granted by larvicides may dramatically offset the cost-benefit balance in favour of the interven-
tion. However, these costs are difficult to estimate because of the lack of sufficient data.
We did not include other arboviroses transmitted by Ae. albopictus because of their lower
epidemiological relevance to the considered area. For example, the risk of Zika virus transmis-
sion was found to be close to zero in the study region, even under conservative scenarios [17].
Nonetheless, we note that larvicides produce simultaneous benefits in preventing multiple dis-
eases transmitted not only by Ae. albopictus but also by other affected mosquito species (e.g.
West Nile virus associated to Culex pipiens L.). Furthermore, larviciding may assist in limiting
the spread of other invasive mosquito species such as Aedes (Hulecoeteomyia) japonicus (Theo-
bald) and Aedes (Hulecoeteomyia) koreicus (Edwards) [1, 27]. An interesting research question
is how the balance of ecological interactions between mosquito species [28] may be offset by
such interventions.
Other studies [2, 6, 7] have investigated the effectiveness of vector control in Europe using
different approaches. The cost-effectiveness of larvicidal treatment against Ae. albopictus in
temperate climates has been evaluated only in combination with other interventions during an
ongoing outbreak [29, 30]; other studies were based on endemic (extra-European) settings
where transmission is mainly mediated by Aedes (Stegomyia) aegypti (Linneus) [31, 32]. Over-
all, results from different studies and approaches, including our own, are consistent in
highlighting the potential of larviciding towards reducing mosquito populations; however, this
reduction will not result in a complete elimination of the risk of local chikungunya or dengue
transmission. Additional strategies may integrate the control of risks from mosquito-borne
diseases, including source reduction methods (e.g. identification and removal of breeding
sites), mass trapping (e.g. via lethal ovitraps) and approaches leveraging ecological interactions
(such as the use of Wolbachia bacteria or the release of genetically sterilized male mosquitoes).
A comprehensive review of the potential for these strategies can be found in [9], but specific
cost-effectiveness studies are needed to identify optimal strategies for vector control. European
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municipalities with temperate climate where Ae. albopictus is established may take advantage
of results from this study when planning and timing routine larviciding interventions aimed
to prevent or reduce epidemiological risks. Temperate European areas share with our study
collection area similar temperature suitability for the transmission of arboviruses [33] and sim-
ilar abundances of Ae. albopictus [34], so that results on the epidemiological effectiveness of
larviciding should not differ significantly. More caution should be paid when extrapolating
cost-effectiveness conclusions to different countries, given potential differences in health and
intervention costs and in the choice of the WTP. Finally, we suggest that the proposed method-
ological approach may also be extended to European areas with different climates, conditional
on the availability of local data on mosquito abundances estimated via entomological surveil-
lance activities.
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